COR Q2 2025 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$69B

Q2 2025 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$75.5B+10.3% YoY

Gross Profit

$2.6B3.5% margin

Operating Income

$1.0B1.3% margin

Net Income

$718M1.0% margin

EPS (Diluted)

$3.68

QoQ Revenue Growth

-7.4%

Cash Flow

Operating Cash Flow

$3.4B

Free Cash Flow

$3.2B

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$71.2B

Total Liabilities

$70.0B

Stockholders' Equity

$1.0B

Cash & Equivalents

$2.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$75.5B	$68.4B	+10.3%
Gross Profit	$2.6B	$2.3B	+15.9%
Operating Income	$1.0B	$869M	+16.9%
Net Income	$718M	$421M	+70.6%

Revenue Segments

Pharmaceutical Distribution

$66.9B89%

International Healthcare Solutions

$7.2B10%

Animal Health

$1.4B2%

Geographic Segments

U.S. Healthcare Solutions

$68.3B90%

International Healthcare Solutions

$7.2B10%